NUTEX HEALTH SCHEDULES 2024 SECOND QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
Nutex Health Inc. (NASDAQ: NUTX), a physician-led integrated healthcare delivery system, has announced its schedule for releasing 2024 second quarter financial results. The company, which operates 21 micro hospitals across 9 states and manages primary care-centric, risk-bearing physician networks, will disclose its financial performance on Thursday, August 8, 2024, after the stock market closes.
A conference call to discuss these results is scheduled for Friday, August 9, 2024, at 10:00 am ET. Investors and interested parties can participate by dialing 1-877-407-9208 or 1-201-493-6784. Alternatively, a webcast will be available for those who prefer to join online. For those unable to attend the live call, a recording will be accessible on the company's website.
Nutex Health Inc. (NASDAQ: NUTX), un sistema integrato di assistenza sanitaria guidato da medici, ha annunciato il programma per la pubblicazione dei risultati finanziari del secondo trimestre 2024. L'azienda, che gestisce 21 micro ospedali in 9 stati e coordina reti di medici incentrate sulla cura primaria e con assunzione di rischio, renderà nota la propria performance finanziaria giovedì 8 agosto 2024, dopo la chiusura del mercato azionario.
Una conferenza telefonica per discutere questi risultati è programmata per venerdì 9 agosto 2024, alle 10:00 ET. Gli investitori e le parti interessate possono partecipare componendo il numero 1-877-407-9208 o 1-201-493-6784. In alternativa, sarà disponibile un webcast per coloro che preferiscono unirsi online. Per chi non riesce a partecipare alla chiamata dal vivo, sarà accessibile una registrazione sul sito web dell'azienda.
Nutex Health Inc. (NASDAQ: NUTX), un sistema de atención médica integrado dirigido por médicos, ha anunciado su calendario para la publicación de resultados financieros del segundo trimestre de 2024. La empresa, que opera 21 microhospitales en 9 estados y gestiona redes de médicos centradas en la atención primaria y asumiendo riesgos, revelará su desempeño financiero el jueves 8 de agosto de 2024, después del cierre del mercado de valores.
Una conferencia telefónica para discutir estos resultados está programada para el viernes 9 de agosto de 2024, a las 10:00 a.m. ET. Los inversores y partes interesadas pueden participar llamando al 1-877-407-9208 o 1-201-493-6784. Alternativamente, estará disponible una transmisión en línea para aquellos que prefieren unirse en línea. Para quienes no puedan asistir a la llamada en vivo, se podrá acceder a una grabación en el sitio web de la empresa.
Nutex Health Inc. (NASDAQ: NUTX)는 의사가 이끄는 통합 의료 서비스 시스템으로, 2024년 2분기 재무 결과 발표 일정을 발표했습니다. 이 회사는 9개 주에 걸쳐 21개의 마이크로 병원을 운영하며, 1차 진료 중심의 위험 부담 의료 네트워크를 관리하고 있습니다. 회사는 2024년 8월 8일 목요일 주식 시장이 마감된 후 재무 성과를 공개할 예정입니다.
이 결과를 논의하기 위한 컨퍼런스 콜은 2024년 8월 9일 금요일 오전 10:00 ET로 예정되어 있습니다. 투자자와 이해 관계자는 1-877-407-9208 또는 1-201-493-6784로 전화하여 참여할 수 있습니다. 대신 온라인 참여를 선호하는 분들을 위해 웹캐스트도 제공됩니다. 라이브 통화에 참석하지 못하는 분들을 위해 회사 웹사이트에서 녹화본을 볼 수 있습니다.
Nutex Health Inc. (NASDAQ: NUTX), un système de santé intégré dirigé par des médecins, a annoncé son calendrier de publication des résultats financiers du deuxième trimestre 2024. L'entreprise, qui gère 21 micro-hôpitaux dans 9 États et coordonne des réseaux de médecins axés sur les soins primaires avec une prise de risque, dévoilera ses performances financières le jeudi 8 août 2024, après la fermeture du marché boursier.
Une conférence téléphonique pour discuter de ces résultats est prévue pour le vendredi 9 août 2024 à 10h00 ET. Les investisseurs et les parties intéressées peuvent participer en composant le 1-877-407-9208 ou 1-201-493-6784. Alternativement, un webinaire sera disponible pour ceux qui préfèrent se joindre en ligne. Pour ceux qui ne peuvent pas assister à l'appel en direct, un enregistrement sera accessible sur le site web de l'entreprise.
Nutex Health Inc. (NASDAQ: NUTX), ein von Ärzten geführtes integriertes Gesundheitsversorgungssystem, hat seinen Zeitplan für die Veröffentlichung der Finanzergebnisse des zweiten Quartals 2024 bekannt gegeben. Das Unternehmen betreibt 21 Mikrokrankenhäuser in 9 Bundesstaaten und verwaltet netzwerkbasierte Arztpraxen, die sich auf primäre Gesundheitsversorgung und Risikobereitschaft konzentrieren. Die Finanzzahlen werden am Donnerstag, den 8. August 2024, nach Börsenschluss veröffentlicht.
Ein Konferenzgespräch zur Diskussion dieser Ergebnisse ist für Freitag, den 9. August 2024, um 10:00 Uhr ET geplant. Investoren und Interessierte können teilnehmen, indem sie die Nummer 1-877-407-9208 oder 1-201-493-6784 wählen. Alternativ wird ein Webcast für diejenigen verfügbar sein, die online teilnehmen möchten. Für diejenigen, die nicht an dem Live-Call teilnehmen können, wird eine Aufzeichnung auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
Participant Dial-In Numbers: 1-877-407-9208 or 1-201-493-6784
Participant webcast: https://viavid.webcasts.com/starthere.jsp?ei=1681991&tp_key=79ea06250d
To access the call, please dial in approximately five minutes before start time. Those who are unable to attend the live conference call may access the recording on the Company's website.
About Nutex Health Inc.
Headquartered in
The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 21 facilities in 9 states.
The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups. Our cloud-based proprietary technology platform aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers, allowing us to deliver greater quality care more efficiently.
Forward-Looking Statements
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "expects to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including final rules implemented under the No Surprises Act and related regulatory guidance, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2023 and in the Quarterly Report on Form 10-Q for the period ended March 31, 2024 under the heading "Risk Factors" in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
View original content:https://www.prnewswire.com/news-releases/nutex-health-schedules-2024-second-quarter-financial-results-release-and-conference-call-302214881.html
SOURCE Nutex Health, Inc.
FAQ
When will Nutex Health (NUTX) release its Q2 2024 financial results?
When is Nutex Health's (NUTX) Q2 2024 earnings conference call scheduled?
How can investors participate in Nutex Health's (NUTX) Q2 2024 earnings call?
How many micro hospitals does Nutex Health (NUTX) operate as of August 2024?
